582 Companies
Oxford BioMedica is a prominent gene and cell therapy company that is devoted to finding cures for critical ailments. The company has pioneered a dominant lentiviral vector delivery platform called...
Oxford Biomedica Annual Report 2023Harpoon Therapeutics Inc., a clinical-stage immunotherapy company based in South San Francisco, is at the forefront of a groundbreaking pursuit to develop a new class of T cell engagers. Utilizing ...
Harpoon Therapeutics Annual Report 2021Cambridge-based KalVista Pharmaceuticals, a clinical stage pharmaceutical company, has announced its plans to discover, develop, and commercialize small molecule protease inhibitors to tackle disea...
KalVista Pharmaceuticals, Inc. Annual Report 2023Intra-Cellular Therapies, a prominent biopharmaceutical firm in the United States, is dedicated to discovering, clinically developing, and commercializing small molecule drugs that address medical ...
Intra-Cellular Therapies Annual Report 2023NovaBay Pharmaceuticals, Inc. is a leading pharmaceutical company with a diverse range of product offerings in the eyecare, skincare, and wound care space. Operating both domestically and internati...
Novabay Pharmaceuticals Annual Report 2023IXICO is a leading provider of neuroimaging services for biopharmaceutical companies. The company offers solutions that help these companies extract clinically relevant insights from their data to ...
IXICO plc Annual Report 2023Bio-Techne Corporation, a leading provider of life science reagents, instruments, and services, is making waves in the global research and clinical diagnostic markets. The company operates through ...
Bio-Techne Annual Report 2023Aravive, Inc., a clinical-stage biopharmaceutical company based in Houston, Texas, is making strides in developing transformative treatments for life-threatening diseases such as cancer and fibrosi...
Aravive, Inc. Annual Report 2021Cizzle Biotechnology Holdings Plc, based in London, is a company that specializes in developing a blood test for the early detection of various forms of lung cancer. The company's focus is on devel...
Cizzle Biotechnology Holdings Plc Annual Report 2023Galmed Pharmaceuticals Ltd., a leading clinical-stage biopharmaceutical company, has set its sights on revolutionizing the treatment of liver diseases through groundbreaking therapeutic development...
Galmed Pharmaceuticals Ltd. Annual Report 2023Forward Pharma A/S is a Danish biopharmaceutical company that has been developing a proprietary formulation of DMF for the treatment of inflammatory and neurological indications. The company grante...
Forward Pharma A/S Annual Report 2020Syndax Pharmaceuticals, a clinical-stage biopharmaceutical company, is currently focused on developing groundbreaking cancer therapies. At the forefront of the company's research are its two main d...
Syndax Pharmaceuticals Annual Report 2023Amicus Therapeutics, a prominent biotechnology firm, is committed to discovering, developing, and providing treatments for rare illnesses. Through its extensive portfolio of commercial products and...
Amicus Therapeutics Annual Report 2023Silence Therapeutics plc, a biotech firm specializing in the discovery and development of innovative RNA therapeutics in areas such as hematology, cardiovascular disease, and rare metabolic conditi...
Silence Therapeutics plc Annual Report 2023Nutritional supplement powerhouse Reliv' International, Inc. continues to develop and market top-tier products that tackle a range of health-related issues including basic nutrition, wellness needs...
Reliv International, Inc. Annual Report 2018